Skip to content
PeptideAgent

Clinics in Hawaii

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

What Hawaii law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and verified listings.

Hawaii at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified clinics serving Hawaii

No verified clinics serving Hawaii are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Peptide access rules in Hawaii

Yes. A Hawaii resident can obtain FDA approved peptides such as semaglutide and tirzepatide by prescription from a Hawaii-licensed physician, including by telehealth under Hawaii Revised Statutes section 453-1.3, but the statute says a prescription based solely on an online questionnaire is not acceptable care and a physician needs a Hawaii license to form a new patient relationship by telehealth. Compounded peptides are available when eligible under federal 503A rules and dispensed by a Hawaii pharmacy or an out-of-state pharmacy holding a Hawaii Board of Pharmacy permit under HRS 461-15. [1] [2] [3] [4] [5] [7]

Compounded GLP-1 access in Hawaii

Because Hawaii rejects questionnaire-only prescribing, patients using national telehealth GLP-1 programs should expect a documented evaluation by a Hawaii-licensed physician, and any out-of-state pharmacy must hold a Hawaii out-of-state pharmacy permit. [2] [4] [8]

Research use only sellers in Hawaii

Only pharmacies permitted by the Hawaii Board of Pharmacy, including out-of-state pharmacies permitted under HRS 461-15, may dispense prescription drugs to Hawaii patients. "Research use only" peptides sold for human injection are unapproved new drugs under federal law and are not dispensed by a pharmacist. The Hawaii Food, Drug, and Cosmetic Act, HRS 328-17(a), separately bars any person from selling, delivering, holding for sale, or giving away a new drug unless an application for it has been approved under section 505 of the federal act (or, for a drug outside the federal act, filed with and not refused by the Hawaii director of health). [4] [6] [9]

Hawaii notes on specific peptides

  • Semaglutide: Available branded by prescription from a Hawaii-licensed physician, including by telehealth after a documented evaluation; HRS 453-1.3 rejects prescriptions based solely on an online questionnaire. Compounded semaglutide is limited to documented patient-specific needs since the 503A grace period ended April 22, 2025. [2] [8]

How to check a clinic in Hawaii

  1. Confirm the prescribing clinician's license with the Hawaii medical or nursing board.
  2. Ask which pharmacy compounds or dispenses the peptide and check it in the Hawaii State Board of Pharmacy (Department of Commerce and Consumer Affairs) license lookup. [1] [4] [5] [7]
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Hawaii. [4] [6] [9]

Common questions in Hawaii

Can I get a GLP-1 prescription in Hawaii from an online questionnaire?

No. HRS 453-1.3 states that a prescription based solely on an online questionnaire is not acceptable care. A Hawaii-licensed physician can prescribe by telehealth after a documented evaluation with history and a discussion of symptoms adequate to reach a diagnosis and rule out contraindications. [2]

Can a doctor licensed in another state start treating me in Hawaii by telehealth?

No. HRS 453-1.3 says a physician may not use telehealth to establish a physician-patient relationship with a patient in Hawaii without a Hawaii medical license. [2]

All peptide legal questions for Hawaii

Sources

  1. [1]Hawaii State Board of Pharmacy, Professional and Vocational Licensing Division
  2. [2]Hawaii Revised Statutes section 453-1.3, Practice of telehealth
  3. [3]Hawaii Revised Statutes chapter 453, sections 453-1 to 453-3 (Hawaii Legislature)
  4. [4]Hawaii Revised Statutes chapter 461, Pharmacists and pharmacy (including sections 461-14 and 461-15)
  5. [5]Hawaii Administrative Rules chapter 16-95, Pharmacists and Pharmacies (compilation, Board of Pharmacy)
  6. [6]Hawaii Revised Statutes section 328-17, New drugs, regulation of sale (Hawaii Legislature)
  7. [7]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  8. [8]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  9. [9]21 U.S.C. 331, Prohibited acts